Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

Affiliations

• ¹ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.
• ² Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
• ³ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
• ⁴ Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
• ⁵ Department of Urology, University Hospitals Leuven, Leuven, Belgium.
• ⁶ Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
• ⁷ Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
• ⁸ VIB Center for Cancer Biology, VIB, Leuven, Belgium.
• ⁹ JJP Biologics, Warsaw, Poland.
• ¹⁰ Histocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.
• ¹¹ Inserm, UMRS-1138, Génomique fonctionnelle des tumeurs solides, Centre de recherche des Cordeliers, Paris, France.
• ¹² Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
• ¹³ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
• ¹⁴ Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
• ¹⁵ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. abhishek.garg@kuleuven.be.